Sharemaestro Newsreel

Teledyne Technologies to Buy Varex Imaging in $1.1 Billion Deal

Teledyne Technologies (TDY) has agreed to acquire X-ray imaging components manufacturer Varex Imagin PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? …

IRhythm grows heart monitoring leadership with $288M VitalConnect buy

IRhythm announced its acquisition of VitalConnect for $287.5 million to expand its mobile cardiac telemetry (MCT) capabilities. This acquisition is expected to unlock access to an additional $500 million market opportunity within the $1 billion cardiac monitoring market. While IRhythm remains committed to securing …

PRGO vs. NEOG: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Perrigo (PRGO) and Neogen (NEOG). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look. Everyone has their own methods …

TFX vs. PEN: Which Stock Is the Better Value Option?

Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. We have found that the best way to …

DexCom stock hits 52-week high at 87.85 USD By Investing.com

DexCom Inc.'s stock reached a 52-week high of $87.85, reflecting strong investor confidence and market sentiment. The company reported robust second-quarter revenue, surpassing analyst estimates, and raised its guidance for the second consecutive quarter. Analysts from RBC Capital, BTIG, Canaccord, TD Cowen, and Piper …

Time To Worry? Analysts Just Downgraded Their AdaptHealth Corp. (NASDAQ:AHCO) Outlook

Analysts have significantly downgraded their near-term forecasts for AdaptHealth Corp. (NASDAQ:AHCO), cutting both revenue and earnings per share estimates for 2026. The consensus now projects a substantial revenue reduction and a loss per share, leading to a 35% drop in the consensus price target. …

Quanterix Q2 Earnings Call Highlights

Key Points Interested in Quanterix Corporation? Here are five stocks we like better. Quanterix cut its 2026 outlook after second-quarter revenue of $32.9 million fell $3 million short of guidance amid broad market weakness and commercial execution challenges. Full-year revenue guidance declined to $142 …

Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?

Abbott Laboratories' ABT Medical Devices remains its largest segment and continues to benefit from a strong pipeline of new product launches and growing adoption across cardiovascular care and diabetes management. The segment is well positioned to capitalize on the expanding global medical devices market. …

ISRG Trades at a Premium P/E: Buy, Sell or Hold the Stock Now?

Intuitive Surgical ISRG currently trades at a forward 12-month P/E ratio of 33.02X, above the Medical - Instruments industry's 26.53X, underscoring a valuation premium that investors must weigh against the company's growth prospects. The stock carries a Value Score of D, suggesting that shares …

Revenue per share of InMode Ltd. – HAM:154

The article focuses on the revenue per share information for InMode Ltd., traded under the ticker HAM:154 on the Hamburg Stock Exchange. It notes that the market is currently closed with no trades. The content is primarily a navigation path within a financial data …

Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims

Abbott Laboratories is opposing the consolidation of spinal cord stimulator lawsuits into a multidistrict litigation (MDL), despite a growing number of claims alleging dangerous defects in its devices. While a similar MDL has already been established for Boston Scientific, Abbott argues that its cases …

Quanterix earnings missed by $0.64, revenue fell short of estimates

Varex Imaging earnings beat by $0.10, revenue fell short of estimates

NNOX Investors Have Opportunity to Lead Nano-X Imaging Ltd. Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nano-X Imaging Ltd. (“Nano-X” or “the Company”) (NASDAQ: NNOX) for violations of §§10(b) and 20(a) of …

Cytosorbents Corp (CTSO) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cytosorbents Corp (CTSO), detailing its current earnings forecast score, average price target from analysts, and expected revenue and EPS for upcoming quarters. One analyst currently rates the stock as "Hold" with a significant upside potential to the …

Axogen stock hits 52-week high at 47.09 USD By Investing.com

Axogen Inc. (AXGN) stock reached a new 52-week high of $47.09, trading at $47.11 with a market capitalization of $2.52 billion, representing a 231.91% surge over the past year. InvestingPro analysis indicates the stock is currently overvalued, yet net income is projected to grow, …

Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Hi

Varex Imaging Corp (NASDAQ: VREX) saw its shares jump 48.4% after reporting better-than-expected Q3 earnings, beating analyst estimates for EPS but missing on sales. The company also announced it would be acquired by Teledyne. Several other companies, including Bowman Consulting Group Ltd, MarineMax Inc, …

Transcript : Quanterix Corporation, Q2 2026 Earnings Call, Aug 10, 2026

Earnings call transcript: Quanterix Q2 2026 revenue miss sends shares down 43%

Quanterix reported Q2 2026 revenue of $32.9 million, significantly missing analyst expectations of $38.06 million and causing shares to drop 43%. The company revised its full-year 2026 revenue guidance downwards and pushed back its cash flow breakeven target to 2027, citing commercial execution issues …

We Said These 4 Dividend Aristocrats Could Soar. Here’s How They Did, Plus 3 New Picks.

Quick Read ABBV surged 47% and BDX gained 26% over the past year, both decisively beating the market as their overlooked dividend growth drove outsized returns. All four original picks kept raising dividends regardless of price, with PG marking its 70th consecutive year of …

Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates

Varex Imaging (NASDAQ:VREX) Sets New 52-Week High on Strong Earnings

Investors Can Question AVITA Medical Executives on Aug. 12

AVITA Medical (NASDAQ: RCEL) will host an investor webinar briefing on August 12, 2026, at 4:00 p.m. Pacific Time (August 13, 2026, 9:00 a.m. AEST). President and CEO Cary Vance and CFO David O’Toole will present financial and business highlights from the recent Q2 …

Senseonics (SENS) Stock Price Jumps On Growth While Losses Deepen

Senseonics Holdings (SENS) saw its stock price jump 36% after reporting strong Q2 2026 revenue growth in continuous glucose monitoring and a sharp lift in gross margin, despite deepening net losses. The market reacted positively to adoption milestones like increased active prescribers and improved …

NNOX EQUITY ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Nano-X Imaging (NNOX) Investors of Securities Class Action Lawsuit Deadline on August 11, 2026

Faruqi & Faruqi, LLP is reminding investors of Nano-X Imaging (NNOX) about a securities class action lawsuit deadline on August 11, 2026. The lawsuit alleges that Nano-X made false and misleading statements regarding its operational efficiency, product demand, and financial health, leading to increased …

Quanterix Corp (QTRX) Misses Q2 Earnings Estimates with EPS at -$1.04 and Revenue of $32.9M; Is the Stock 65.9% Undervalued? GF Score: 63/100

Quanterix Corp (QTRX) reported its Q2 2026 financial results, missing analyst estimates with a revenue of $32.9 million against an expected $37.46 million, and an adjusted loss per share of $1.04 compared to a forecasted $0.40 loss. Despite challenges like market softness and execution …

VAREX IMAGING (VREX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Earnings To Watch: Spectral AI Inc (MDAI) Q2 2026 -- GF Value Sees 60% Downside

PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down

Insulet Corporation PODD reported second-quarter 2026 adjusted earnings per share (EPS) of $1.66, up 41.5% year over year. The bottom line beat the Zacks Consensus Estimate by 15.28%. GAAP EPS came in at $1.37 compared with the year-ago quarter's figure of 32 cents. Revenues …

Varex Imaging (NASDAQ:VREX) Receives "Neutral" Rating from Sidoti

Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock

Have you assessed how the international operations of Bio-Rad Laboratories (BIO) performed in the quarter ended June 2026? For this maker of instruments used in biomedical research, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its …

Brainsway Ltd expected to post earnings of 7 cents a share - Earnings Preview

Brainsway Ltd is expected to report earnings of 7 cents per share, according to a Reuters earnings preview available on TradingView. The article title serves as the primary information, with further details behind a paywall.

Envoy Medical (NASDAQ:COCH) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Teledyne To Buy Varex Imaging For About $1.1 Bln In Cash

(RTTNews) - Teledyne Technologies Inc. (TDY) announced on Monday that it has agreed to buy Varex Imaging Corp. (VREX) for $18.90 per share in cash, valuing the deal at about $1.1 billion, including debt and equity awards as of April 3, 2026. The transaction …

High-flyer healthcare stocks: Ten names with strong momentum, weak valuations

[Heart Health Concept] Eoneren/E+ via Getty Images Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price velocity against fundamental underlying valuations. Analysts warn that chasing recent momentum can …

BofA Securities Adjusts HCA Healthcare Price Target to $425 From $400

BofA Securities has raised its price target for HCA Healthcare (HCA) shares to $425 from $400. This adjustment was published on August 10, 2026, at 08:48 am EDT, according to MT Newswires. HCA Healthcare specializes in owning and operating healthcare facilities, including 190 hospitals …